Advertisement

Investigation of a MOSFET dosimetry system for midpoint dose verification in prostate 3D CRT/IMRT

  • T. Wiese
  • E. Bezak
  • R. Nelligan
Scientific Paper

Abstract

The suitability of MOSFETs (Metal Oxide Semiconductor Field Effect Transistors) for use in in-vivo dosimetry for IMRT prostate treatment and patient setup errors has been investigated in this work. MOSFETs were placed on entrance and exit surfaces of a number of different phantoms (with varying complexities from homogeneous to anthropomorphic). Dose measurements were then used to calculate a midpoint dose, which was compared with an IC placed at the isocentre. The agreements found between the calculated (MOSFETs) and the measured midpoint dose (IC) was: 0.7 % for a prostate treatment verification and 3.5 % for an IMRT treatment. MOSFETs placed on entry and exit surfaces can detect patient setup offsets of 2 cm, but do not have the sensitivity to confidently detect offsets of 1 cm or smaller.

Key words

in-vivo dosimetry MOSFET prostate treatment IMRT 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Varadhan, R., Miller, J., Garrity, B. and Weber, M.,In vivo prostate IMRT dosimetry with MOSFET detectors using brass buldup caps, Jnl. Appl. Clin. Med. Phys., 7(4), p. 22–32, 2006.Google Scholar
  2. 2.
    Chuang, C.F., Verhey, L.J. and Xia, P.,Investigation of the use of MOSFET for clinical IMRT dosimetric verification, Med. Phys. 29(6), p.1109–1115, 2002.CrossRefPubMedGoogle Scholar
  3. 3.
    Broggi, S., Fiorino, C. and Calandrino, R.,A simple and robust method for in-vivo midline dose map estimations using diodes and portal detectors, Radiother Oncol., 58(2), p. 169–78, 2001.CrossRefPubMedGoogle Scholar
  4. 4.
    Jones, A.O. and Kleiman, M.T.,Patient setup and verification for intensity modulated radiation therapy (IMRT), Medical Dosimetry, 28(3), p. 175–183, 2003.CrossRefPubMedGoogle Scholar
  5. 5.
    Oldham, T.R. and McLean, F.B.,Total ionizing dose effects in MOS Oxides and devices, IEEE Transactions on Nuclear Science, 50(3), p. 483, 2003.CrossRefGoogle Scholar
  6. 6.
    Rosenfeld, A.B.,MOSFET dosimetry on modern radiation oncology modalities, Radiation Protection Dosimetry, 101, (1–4), p. 393–398, 2002PubMedGoogle Scholar
  7. 7.
    Huyskens D., Van Dam J. and Dutreix A.,Midplane dose determination using in-vivo dose measurements in combination with portal imaging, Phys. Med. Biol., 39, p. 1089–1101, 1994.CrossRefPubMedGoogle Scholar
  8. 8.
    Noel, D. and Taylor R., Med. Phys., July 15(3): 254–307, 1994Google Scholar
  9. 9.
    International Commission on Radiation Units and Measurements (ICRU) Report 50:Prescribing, Recording and Reporting Photon Beam Therapy, 1987.Google Scholar
  10. 10.
    Bridier, A and Dutreix, A,A method for dose calculation for high energy photon beams based on measurements performed at reference depth, Acta Oncol. 32(4), p. 525–533, 1993.CrossRefGoogle Scholar

Copyright information

© Australasian College of Physical Scientists and Engineers in Medicine 2008

Authors and Affiliations

  1. 1.Department of Medical PhysicsRoyal Adelaide HospitalAdelaideAustralia
  2. 2.Department of PhysicsUniversity of AdelaideAustralia

Personalised recommendations